ໜ້າທຳອິດTEVA • NYSE
add
Teva Pharmaceutical Industries Ltd
$17,12
ຫຼັງປິດຕະຫຼາດ:(0,47%)-0,080
$17,04
ປິດແລ້ວ: 22 ພ.ຈ., 17 ໂມງ 5 ນາທີ 00 ວິນາທີ GMT-5 · USD · NYSE · ຂໍ້ຈຳກັດຄວາມຮັບຜິດຊອບ
ປິດກ່ອນໜ້າ
$17,08
ຂອບເຂດລາຄາໃນມື້
$16,86 - $17,13
ຂອບເຂດລາຄາໃນປີ
$9,35 - $19,31
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
19,29 ຕື້ USD
ປະລິມານສະເລ່ຍ
6,78 ລ້ານ
ໃນຂ່າວ
ການເງິນ
ໃບລາຍງານຜົນໄດ້ຮັບ
ລາຍໄດ້
ລາຍໄດ້ສຸດທິ
(USD) | ກ.ຍ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ | 4,33 ຕື້ | 12,52% |
ຄ່າໃຊ້ຈ່າຍການດຳເນີນການ | 1,14 ຕື້ | 5,05% |
ລາຍໄດ້ສຸດທິ | -437,00 ລ້ານ | -733,33% |
ສ່ວນແບ່ງກຳໄລສຸດທິ | -10,09 | -663,69% |
ລາຍໄດ້ຕໍ່ຮຸ້ນ | 0,69 | 15,00% |
EBITDA | 1,26 ຕື້ | 20,98% |
ອັດຕາອາກອນທີ່ມີຜົນ | -21,50% | — |
ໃບດຸ່ນດ່ຽງ
ຊັບສິນທັງໝົດ
ໜີ້ສິນທັງໝົດ
(USD) | ກ.ຍ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ເງິນສົດ ແລະ ລົງທຶນໄລຍະສັ້ນ | 3,32 ຕື້ | 47,58% |
ຊັບສິນທັງໝົດ | 41,76 ຕື້ | -0,78% |
ໜີ້ສິນທັງໝົດ | 35,37 ຕື້ | 2,31% |
ຫຸ້ນທຶນທັງໝົດ | 6,38 ຕື້ | — |
ຮຸ້ນທີ່ຄ້າງຈ່າຍ | 1,13 ຕື້ | — |
ລາຄາຕໍ່ມູນຄ່າທາງບັນຊີ | 3,19 | — |
ລາຍຮັບຈາກຊັບສິນ | 6,04% | — |
ລາຍຮັບຈາກທຶນ | 9,82% | — |
ກະແສເງິນສົດ
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ
(USD) | ກ.ຍ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ສຸດທິ | -437,00 ລ້ານ | -733,33% |
ເງິນສົດຈາກການດໍາເນີນງານ | 693,00 ລ້ານ | 13.760,00% |
ເງິນສົດຈາກການລົງທຶນ | 268,00 ລ້ານ | 45,65% |
ເງິນສົດຈາກການເງິນ | — | — |
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ | 1,06 ຕື້ | 352,62% |
ການເງິນສະພາບຄ່ອງ | 1,28 ຕື້ | 62,91% |
ກ່ຽວກັບ
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
ສ້າງຕັ້ງ
13 ກ.ພ. 1944
ເວັບໄຊ
ພະນັກງານ
37.000